Combining light therapy with CPAP for treating depression
Official title: Effects of Light Therapy on Compliance With Continuous Positive Airway Pressure in a Population of Depressed Patients Newly Fitted With Devices for Obstructive Sleep Apnea
Run by Hôpital le Vinatier · NCT06781593 · Data updated 2026-11-12
This study is testing if adding light therapy to CPAP treatment can help adults with depression and sleep apnea stick to their therapy better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | Hôpital le Vinatier Academic / other |
| Locations | 2 sites (Bron, France and 1 other locations) |
| Status | Recruiting |
| Started | January 17, 2025 |
| Main results expected | October 30, 2027 |
| Study ends | October 30, 2027 |
| Registry record updated | April 29, 2025 |
| Trial ID | NCT06781593 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults diagnosed with major depressive disorder and obstructive sleep apnea who require CPAP treatment.
✕Probably not a fit
Patients with unstable psychiatric conditions or contraindications to light therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of two weeks of light therapy combined with continuous positive airway pressure (CPAP) on improving compliance in patients suffering from major depressive disorder (MDD) and obstructive sleep apnea (OSA). The study aims to recruit 130 adults diagnosed with MDD and OSA, assessing whether the addition of light therapy can enhance adherence to CPAP treatment. The trial is designed as a double-blind, parallel-group controlled trial, focusing on the relationship between sleep disturbances and depressive symptoms. By addressing both conditions simultaneously, the study seeks to improve overall patient outcomes.
Why it matters
Potential benefit: If successful, this approach could significantly improve CPAP compliance and alleviate depressive symptoms in patients with MDD and OSA.
How similar studies have gone: While the combination of light therapy and CPAP is a novel approach, existing studies have shown that treating sleep disturbances can improve depressive symptoms.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults consulting at the MICHEL JOUVET unit, CH Le Vinatier, Bron * Adults with a diagnosis of major depressive episode (DSM-V) and with a MADRS score ≥ 15 * Adults with a diagnosis of OSAS on ventilatory polygraphy or polysomnography (AASM 2017 criteria) requiring CPAP. Exclusion Criteria: * Refusal to participate. * Pregnant and breast-feeding women * Under guardianship or curatorship. * Unstable psychiatric or physical pathology (e.g., hypomania, high suicidal risk) considered incompatible with the study by the investigators. * Other psychiatric, neurologic or somatic conditions * Contraindication to light therapy: retinopathy, retinitis pigmentosa, diabetic retinopathy, macular degeneration, glaucoma, recent eye surgery (less than 3 months). patient wishing to choose a provider other than the protocol provider. * Patient wishing to choose a device other than SEFAM's S-BOX or a mask other than the nasal mask at the time of introduction. * Nasal obstruction. * Refusal to use actimetry, refusal to use light therapy, refusal to use CPAP.
Where it's running
-
Centre Hospitalier le Vinatier
Bron, France, France Recruiting -
Centre Hospitalier le Vinatier
Bron, France Not yet recruiting
Study contacts
- Principal investigator: Sébastien S CATOIRE, DR — Centre Hospitalier le Vinatier
- Study coordinator: Sébastien S CATOIRE, Dr
- Email: sebastien.catoire@ch-le-vinatier.fr
- Phone: +330437915495
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can tACS modulate motivation and reward signals in cannabis use disorder and depression
We’re testing whether a gentle brain stimulation method (tACS) can boost motivation and reward responses in adults with cannabis use and/or depression to see if it helps with anhedonia.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Neural links for real-world emotions in mood and anxiety
Researchers are testing how real-life emotional moments relate to brain activity and stress responses in young adults with mood and anxiety symptoms, using smartphones, self-reports, tasks, and MRI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.